Patients who received heart transplants from hepatitis C virus-positive vs -negative donors were found to have comparable survival at 1 year and patients who developed transplant-related hepatitis C responded well to treatment.
Exposure to air pollution may be associated with increased patient mortality after heart transplantation.
Five-year survival benefit following heart transplant varies widely across transplant centers.
Estimated mortality hazard ratio 1.43 per 10 µg/m³ increment increase in annual PM2.5 exposure
Early observations show lower waitlist mortality, but higher posttransplant mortality or retransplantation.
Although an independent association was not identified between pulmonary vascular resistance and conditional 1-year mortality, it was identified between pulmonary vascular resistance and 30-day mortality.
In the context of cardiac surgery, there is no indication of a “July effect,” describing worse outcomes in the first month of training.
Transfusing red blood cells into cardiac surgery patients only when their hemoglobin levels fall to below 7.5 g/dL does not increase acute kidney injury risk.
Patients with idiopathic pulmonary artery hypertension undergoing a lung transplant in which extracorporeal life support is needed experienced poorer outcomes compared with patients with other diagnoses.
Restrictive approach does not increase risk for acute kidney injury in high-risk patients.